Back
XTL Biopharmaceuticals Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
41
XTLB
XTL Biopharmaceuticals
Last Price:
1.88
Seasonality Move:
6.1%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing slight selling pressure.
XTL Biopharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.86 | Buy |
| 20-day SMA: | 1.97 | Sell |
| 50-day SMA: | 2.32 | Sell |
| 200-day SMA: | 2.17 | Sell |
| 8-day EMA: | 1.96 | Sell |
| 20-day EMA: | 2.01 | Sell |
| 50-day EMA: | 2.22 | Sell |
| 200-day EMA: | 2.14 | Sell |
XTL Biopharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 45.64 | Sell |
| Chaikin Money Flow: | -24344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.75 - 2.35) | Sell |
| Bollinger Bands (100): | (2.11 - 2.75) | Sell |
XTL Biopharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for XTL Biopharmaceuticals Stock
Is XTL Biopharmaceuticals Stock a Buy?
- XTL Biopharmaceuticals share price is 1.88 while XTLB 8-day simple moving average is 1.86, which is a Buy signal.
- The stock price of XTLB is 1.88 while XTL Biopharmaceuticals 20-day SMA is 1.97, which makes it a Sell.
- XTL Biopharmaceuticals 50-day simple moving average is 2.32 while XTLB share price is 1.88, making it a Sell technically.
- XTLB stock price is 1.88 and XTL Biopharmaceuticals 200-day simple moving average is 2.17, creating a Sell signal.
XTLB Technical Analysis vs Fundamental Analysis
Sell
41
XTL Biopharmaceuticals (XTLB)
is a Sell
Is XTL Biopharmaceuticals a Buy or a Sell?
-
XTL Biopharmaceuticals stock is rated a Sell
The current XTL Biopharmaceuticals [XTLB] share price is $1.88. The Score for XTLB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
XTL Biopharmaceuticals Stock Info
Market Cap:
10.24M
Price in USD:
1.88
Share Volume:
53.56K
XTL Biopharmaceuticals 52-Week Range
52-Week High:
4.99
52-Week Low:
0.76
Sell
41
XTL Biopharmaceuticals (XTLB)
is a Sell
XTL Biopharmaceuticals Share Price Forecast
-
What is the XTL Biopharmaceuticals stock price today?
The XTL Biopharmaceuticals stock price is 1.88 USD today. -
Will XTLB stock go up or go down?
XTL Biopharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is XTL Biopharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, XTL Biopharmaceuticals is overvalued.
Is XTL Biopharmaceuticals Stock a Buy?
- XTL Biopharmaceuticals share price is 1.88 while XTLB 8-day exponential moving average is 1.96, which is a Sell signal.
- The stock price of XTLB is 1.88 while XTL Biopharmaceuticals 20-day EMA is 2.01, which makes it a Sell.
- XTL Biopharmaceuticals 50-day exponential moving average is 2.22 while XTLB share price is 1.88, making it a Sell technically.
- XTLB stock price is 1.88 and XTL Biopharmaceuticals 200-day simple moving average is 2.14, creating a Sell signal.
Technical Analysis of XTL Biopharmaceuticals
Should I short XTL Biopharmaceuticals stock?
- XTLB Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting XTL Biopharmaceuticals is a Sell
- XTL Biopharmaceuticals Relative Strength Index (RSI) is 45.64, which suggest XTL Biopharmaceuticals is oversold
- The Bollinger Bands (25) for XTL Biopharmaceuticals is (1.75 - 2.35), which suggest XTL Biopharmaceuticals is a Sell
- The Bollinger Bands (100) for XTL Biopharmaceuticals is (2.11 - 2.75), which suggest XTL Biopharmaceuticals is a Sell
* XTL Biopharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.